[1]
Márió Gajdács et al. 2021. Relevance of Achromobacter xylosoxidans in Non-Respiratory Tract Clinical Samples over a Decade (2008-2017): Findings from a Clinical Center in Southern Hungary. Technological Innovation in Pharmaceutical Research Vol. 1. (Feb. 2021), 16–24. DOI:https://doi.org/10.9734/bpi/tipr/v1/2321E.